Incyte Shares Outstanding 2006-2019 | INCY

Incyte shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Incyte shares outstanding for the quarter ending March 31, 2019 were 0.217B, a 2.54% increase year-over-year.
  • Incyte 2018 shares outstanding were 0.216B, a 5.4% increase from 2017.
  • Incyte 2017 shares outstanding were 0.205B, a 5.39% increase from 2016.
  • Incyte 2016 shares outstanding were 0.194B, a 3.64% increase from 2015.
Incyte Annual Shares Outstanding
(Millions of Shares)
2018 216
2017 205
2016 194
2015 187
2014 168
2013 148
2012 130
2011 125
2010 122
2009 103
2008 90
2007 84
2006 84
2005 83
Incyte Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 217
Q4 2018 216
Q3 2018 216
Q2 2018 215
Q1 2018 212
Q4 2017 205
Q3 2017 213
Q2 2017 205
Q1 2017 195
Q4 2016 194
Q3 2016 194
Q2 2016 193
Q1 2016 193
Q4 2015 187
Q3 2015 181
Q2 2015 186
Q1 2015 172
Q4 2014 168
Q3 2014 189
Q2 2014 168
Q1 2014 165
Q4 2013 148
Q3 2013 155
Q2 2013 142
Q1 2013 134
Q4 2012 130
Q3 2012 131
Q2 2012 138
Q1 2012 127
Q4 2011 125
Q3 2011 126
Q2 2011 125
Q1 2011 123
Q4 2010 122
Q3 2010 122
Q2 2010 128
Q1 2010 120
Q4 2009 103
Q3 2009 98
Q2 2009 98
Q1 2009 97
Q4 2008 90
Q3 2008 92
Q2 2008 85
Q1 2008 85
Q4 2007 84
Q3 2007 84
Q2 2007 84
Q1 2007 84
Q4 2006 84
Q3 2006 84
Q2 2006 84
Q1 2006 84
Q4 2005 83
Q3 2005 83
Q2 2005 83
Q1 2005 83
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.522B $1.882B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.282B 12.13
Gilead Sciences (GILD) United States $82.754B 10.05
Celgene (CELG) United States $63.100B 10.69
Biogen (BIIB) United States $45.076B 8.56
Vertex Pharmaceuticals (VRTX) United States $44.586B 53.90
Illumina (ILMN) United States $43.847B 50.81
CSL (CSLLY) Australia $35.477B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.403B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.429B 15.52
Exact Sciences (EXAS) United States $14.987B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.612B 0.00
SINO PHARMACEUT (SBMFF) China $14.357B 0.00
Seattle Genetics (SGEN) United States $12.302B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Sarepta Therapeutics (SRPT) United States $10.732B 0.00
Array BioPharma (ARRY) United States $10.407B 0.00
Galapagos (GLPG) Belgium $9.614B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $9.002B 29.57
Guardant Health (GH) United States $8.169B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.138B 0.00
Bio-Techne Corp (TECH) United States $7.906B 53.94
Bluebird Bio (BLUE) United States $7.710B 0.00
Exelixis (EXEL) United States $6.485B 16.53
BeiGene (BGNE) Cayman Islands $6.041B 0.00
Amarin (AMRN) Ireland $5.976B 0.00
Ascendis Pharma (ASND) Denmark $5.009B 0.00
Blueprint Medicines (BPMC) United States $4.876B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.789B 0.00
Moderna (MRNA) United States $4.623B 0.00
Horizon Pharma Public (HZNP) Ireland $4.434B 11.42
Repligen (RGEN) United States $4.169B 103.86
Mirati Therapeutics (MRTX) United States $3.808B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.744B 0.00
Spark Therapeutics (ONCE) United States $3.703B 0.00
China Biologic Products (CBPO) China $3.670B 23.31
Ultragenyx Pharmaceutical (RARE) United States $3.627B 0.00
Alkermes (ALKS) Ireland $3.582B 0.00
MorphoSys AG (MOR) Germany $3.523B 0.00
Arena Pharmaceuticals (ARNA) United States $3.088B 6.27
Immunomedics (IMMU) United States $2.967B 0.00
Amicus Therapeutics (FOLD) United States $2.936B 0.00
Reata Pharmaceuticals (RETA) United States $2.712B 0.00
Medicines (MDCO) United States $2.698B 0.00
UniQure (QURE) Netherlands $2.681B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.613B 0.00
MyoKardia (MYOK) United States $2.499B 0.00
Halozyme Therapeutics (HALO) United States $2.395B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.338B 0.00
NeoGenomics (NEO) United States $2.216B 145.06
Acceleron Pharma (XLRN) United States $2.213B 0.00
Ligand Pharmaceuticals (LGND) United States $2.198B 18.20
Emergent Biosolutions (EBS) United States $2.194B 19.06
Zai Lab (ZLAB) China $2.111B 0.00
Genomic Health (GHDX) United States $2.087B 44.32
Akcea Therapeutics (AKCA) United States $2.081B 0.00
Myriad Genetics (MYGN) United States $2.034B 20.23
Intercept Pharmaceuticals (ICPT) United States $1.997B 0.00
Denali Therapeutics (DNLI) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.853B 0.00
Insmed (INSM) United States $1.685B 0.00
RA PHARMCTL INC (RARX) United States $1.522B 0.00
Cambrex (CBM) United States $1.495B 18.90
AnaptysBio (ANAB) United States $1.483B 0.00
Fate Therapeutics (FATE) United States $1.465B 0.00
Sangamo Therapeutics (SGMO) United States $1.366B 0.00
Innoviva (INVA) United States $1.333B 3.69
Athenex (ATNX) United States $1.310B 0.00
Alector (ALEC) United States $1.302B 0.00
Editas Medicine (EDIT) United States $1.220B 0.00
Epizyme (EPZM) United States $1.191B 0.00
Coherus BioSciences (CHRS) United States $1.183B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.159B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.057B 0.00
Twist Bioscience (TWST) United States $1.031B 0.00
Cara Therapeutics (CARA) United States $1.028B 0.00
Codexis (CDXS) United States $1.005B 0.00
ANI Pharmaceuticals (ANIP) United States $0.979B 17.36
Momenta Pharmaceuticals (MNTA) United States $0.961B 0.00
Zymeworks (ZYME) Canada $0.952B 0.00
Principia Biopharma (PRNB) United States $0.928B 0.00
Adverum Biotechnologies (ADVM) United States $0.904B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.903B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.860B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.811B 0.00
Intellia Therapeutics (NTLA) United States $0.806B 0.00
Arvinas (ARVN) United States $0.800B 0.00
WAVE Life Sciences (WVE) Singapore $0.775B 0.00
Precision BioSciences (DTIL) United States $0.706B 0.00
Zealand Pharma (ZEAL) Denmark $0.702B 8.20
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Cytokineticsorporated (CYTK) United States $0.671B 0.00
Intra-Cellular Therapies (ITCI) United States $0.661B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.657B 31.02
Cellectis S.A (CLLS) France $0.648B 0.00
Heska (HSKA) United States $0.617B 63.16
DBV Technologies S.A (DBVT) France $0.595B 0.00
Anika Therapeutics (ANIK) United States $0.582B 19.88
Autolus Therapeutics (AUTL) United Kingdom $0.581B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.579B 0.00
Stemline Therapeutics (STML) United States $0.577B 0.00
Clovis Oncology (CLVS) United States $0.575B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Revance Therapeutics (RVNC) United States $0.560B 0.00
MiMedx (MDXG) United States $0.524B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.497B 0.00
CytomX Therapeutics (CTMX) United States $0.492B 0.00
PHARMA MAR SA (PHMMF) Spain $0.454B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.437B 0.00
UROGEN PHARMA (URGN) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.393B 0.00
Puma Biotechnology (PBYI) United States $0.387B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.382B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 24.43
Arcus Biosciences (RCUS) United States $0.377B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Bellus Health (BLUSF) Canada $0.370B 0.00
PDL BioPharma (PDLI) United States $0.367B 8.77
Gritstone Oncology (GRTS) United States $0.364B 0.00
Starpharma Holdings (SPHRY) Australia $0.360B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.345B 0.00
Merus (MRUS) Netherlands $0.342B 0.00
BioDelivery Sciences (BDSI) United States $0.341B 0.00
Biofrontera AG (BFRA) Germany $0.341B 0.00
Scholar Rock Holding (SRRK) United States $0.334B 0.00
Kadmon Holdings (KDMN) United States $0.331B 0.00
Agenus (AGEN) United States $0.328B 0.00
Prometic Life Sciences (PFSCD) Canada $0.322B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Acorda Therapeutics (ACOR) United States $0.317B 5.58
Sorrento Therapeutics (SRNE) United States $0.315B 0.00
Theratechnologies (THERF) Canada $0.310B 0.00
Protagonist Therapeutics (PTGX) United States $0.303B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.297B 0.00
Senesco Technologies (ELOX) United States $0.293B 0.00
Inovio Pharmaceuticals (INO) United States $0.276B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.256B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Kindred Biosciences (KIN) United States $0.247B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
PHASEBIO PHARMA (PHAS) United States $0.240B 0.00
Kamada (KMDA) Israel $0.239B 9.27
Pieris Pharmaceuticals (PIRS) United States $0.228B 0.00
Dynavax Technologies (DVAX) United States $0.218B 0.00
Geron (GERN) United States $0.216B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.215B 0.00
Athersys (ATHX) United States $0.214B 0.00
Palatin Technologies (PTN) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.209B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.198B 0.00
MannKind (MNKD) United States $0.197B 0.00
Cerecor (CERC) United States $0.194B 0.00
Mersana Therapeutics (MRSN) United States $0.192B 0.00
Pfenex (PFNX) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
Affimed (AFMD) Germany $0.183B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.175B 0.00
XOMA (XOMA) United States $0.171B 0.00
Compugen (CGEN) Israel $0.171B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Synlogic (SYBX) United States $0.164B 0.00
BioTime (BTX) United States $0.163B 10.90
Arsanis (XFOR) United States $0.162B 0.00
Nicox SA (NICXF) France $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
Cue Biopharma (CUE) United States $0.148B 0.00
Liquidia Technologies (LQDA) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.145B 8.34
OvaScience (MLND) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.138B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
TOCAGEN INC (TOCA) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.124B 0.00
NantKwest (NK) United States $0.123B 0.00
Aptinyx (APTX) United States $0.120B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.111B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.108B 0.00
Novavax (NVAX) United States $0.108B 0.00
Arbutus Biopharma (ABUS) Canada $0.107B 0.00
Aduro Biotech (ADRO) United States $0.106B 0.00
Verastem (VSTM) United States $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.102B 0.00
Checkpoint Therapeutics (CKPT) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
SESEN BIO, INC (SESN) United States $0.094B 0.00
Trevena (TRVN) United States $0.088B 0.00
Pluristem Therapeutics (PSTI) Israel $0.085B 0.00
Fortress Biotech (FBIO) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Curis (CRIS) United States $0.083B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.082B 0.00
VBI Vaccines (VBIV) United States $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.079B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.077B 0.00
Unum Therapeutics (UMRX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 39.10
AquaBounty Technologies (AQB) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Antibe Therapeutics (ATBPF) Canada $0.059B 0.00
ARAVIVE, INC (ARAV) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.056B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.043B 0.29
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
AEterna Zentaris (AEZS) United States $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Apricus Biosciences (SEEL) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aytu Bioscience (AYTU) United States $0.028B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Vical (VICL) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.006B 0.00
Neuralstem (CUR) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Stellar Biotechnologies (EDSA) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.004B 0.00